Immune cell test may predict kidney graft problems
NCT ID NCT04414111
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether measuring a specific type of immune cell (called highly suppressive Treg) before a kidney transplant can predict if the new kidney will work slowly or need dialysis. Researchers will test blood samples from 180 adult kidney transplant candidates. The goal is to find a reliable biomarker to guide organ allocation and reduce complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors match donated kidneys to patients less likely to have complications, and guide new immune-based treatments.
- What could go wrong
- This is an observational biomarker study, not a treatment trial. The test may not accurately predict outcomes, and results may not change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DGF are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Loma Linda University Health Transplantation Institute
San Bernardino, California, 92408, United States
-
Saint Louis University
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine shield transplant patients from shingles?
- Can a single drug dose forecast transplant kidney health?
- Pre-Surgery bootcamp may boost kidney transplant recovery
- Simple bathroom habit may cut infection risk after kidney transplant
- Urine test may catch kidney rejection before it's too late
- Baking soda study for kidney patients pulled before it started